American biopharmaceutical company, Gilead Sciences has launched Come Chat (COVID-19 Middle East Chatbot), a new application that provides important research updates and the most up-to-date international management guidelines on COVID-19 care.
As per the reports, the guidelines include those on the timely use of antivirals medicines for COVID-19, and this app is intended to be used only by healthcare providers (HCPs) practicing in Kuwait.
The application, which is available on Google Play and App Stores as well as a web edition, contains the most up-to-date clinical COVID-19 results, including safety and efficacy data from global reported clinical trials.
“Ever since the novel coronavirus that causes COVID-19 was identified, the team has been working to support governments and the medical community with our decades of expertise in antiviral research and development. The more than a decade worth of investment and research on Gilead’s antivirals has been critical in our progress in treating COVID-19 and to help meet patient needs. True to our purpose Creating Possible, through Come Chat that employs state-of-the-art machine learning technology, we want to support healthcare professionals by closing any information gaps to ensure better patient outcomes.”
Dr. Ayman El-Sayes, Middle East Medical Director, Gilead Sciences said, “Kuwait has made considerable strides in COVID-19 management fast-tracking necessary authorizations for treatment options including antivirals.”
“However, there needs to be standardized processes and procedures to ensure the best patient outcomes. Educational platforms that provide easy access to scientific information such as Come Chat can drive the necessary education for trained clinicians to make informed decisions,” he further added.
Scientific information will be updated on Come Chat regularly as the COVID-19 pandemic continues to drive data and learnings to clinicians around the world. Come Chat covers a wide variety of information on COVID-19 including international and local guidelines, key published studies on all related treatments, new virus variants, and more, as per the company statement.
Headquartered in California, Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The firm intends to improve and simplify treatment for people suffering from life-threatening illnesses all over the world. It operates in more than 35 countries around the world.